U.S. flag

An official website of the United States government

NM_012193.4(FZD4):c.827del (p.Gly276fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002839440.2

Allele description

NM_012193.4(FZD4):c.827del (p.Gly276fs)

Genes:
FZD4:frizzled class receptor 4 [Gene - OMIM - HGNC]
PRSS23:serine protease 23 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11q14.2
Genomic location:
Preferred name:
NM_012193.4(FZD4):c.827del (p.Gly276fs)
HGVS:
  • NC_000011.10:g.86951930del
  • NG_011752.1:g.8463del
  • NG_011752.2:g.8466del
  • NM_012193.4:c.827delMANE SELECT
  • NP_036325.2:p.Gly276fs
  • NC_000011.9:g.86662971del
  • NC_000011.9:g.86662972del
  • NR_120591.3:n.1293del
  • NR_120592.2:n.1042del
Protein change:
G276fs
Molecular consequence:
  • NM_012193.4:c.827del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_120591.3:n.1293del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_120592.2:n.1042del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003219515Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 22, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy.

Toomes C, Bottomley HM, Scott S, Mackey DA, Craig JE, Appukuttan B, Stout JT, Flaxel CJ, Zhang K, Black GC, Fryer A, Downey LM, Inglehearn CF.

Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2083-90.

PubMed [citation]
PMID:
15223780

Identification of FZD4 and LRP5 mutations in 11 of 49 families with familial exudative vitreoretinopathy.

Yang H, Li S, Xiao X, Wang P, Guo X, Zhang Q.

Mol Vis. 2012;18:2438-46. Epub 2012 Oct 4.

PubMed [citation]
PMID:
23077402
PMCID:
PMC3472927
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV003219515.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FZD4 protein in which other variant(s) (p.Gln505*) have been determined to be pathogenic (PMID: 15223780, 23077402). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with FZD4-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly276Alafs*29) in the FZD4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 262 amino acid(s) of the FZD4 protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024